These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10832148)

  • 41. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.
    Puma JA; Sketch MH
    J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation.
    Cohen M; Antman EM
    Thromb Haemost; 2002 Nov; 88(5):884-6; 886-7. PubMed ID: 12428118
    [No Abstract]   [Full Text] [Related]  

  • 43. Recent clinical trials in acute coronary syndromes without persistent ST elevation.
    Tolleson TR; Harrington RA
    Curr Opin Cardiol; 1999 Sep; 14(5):403-11. PubMed ID: 10500902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antithrombotic drugs in the acute coronary syndrome].
    Jareño Chaumel A; Cercas Sánchez A
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):26-38. PubMed ID: 9139329
    [No Abstract]   [Full Text] [Related]  

  • 45. Treating acute coronary insufficiency with antibiotics.
    Milani KS
    J Fam Pract; 1997 Nov; 45(5):379. PubMed ID: 9374959
    [No Abstract]   [Full Text] [Related]  

  • 46. Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation.
    Borja J; Olivella P
    Thromb Haemost; 2002 Mar; 87(3):538. PubMed ID: 11916089
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intravenous thrombolysis in the acute phase of myocardial infarct].
    de Fuster C
    Soins Cardiol; 1985 May; (27):47-8. PubMed ID: 3848147
    [No Abstract]   [Full Text] [Related]  

  • 48. Heparins in management of acute coronary syndromes without ST-segment elevation.
    Becker RC
    Lancet; 2000 Jun; 355(9219):1926-8. PubMed ID: 10859033
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical trials of low-molecular-weight heparins in cardiology.
    Spinler SA
    Pharmacotherapy; 1999 Sep; 19(9 Pt 2):147S-154S. PubMed ID: 10610005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary thrombolysis: progress and promise.
    Sobel BE
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S910-3. PubMed ID: 6084148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Non-revascularisation of acute coronary syndrome with ST elevation].
    Zeller M; Dentan G; Hamou KH; Beer JC; L'Huillier I; Janin-Manificat L; Makki H; Laurent Y; Louis P; Cottin Y; Wolf JE
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):195-200. PubMed ID: 15106742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Inhibition of thrombocyte aggregation. Current trends in the treatment of acute coronary syndromes].
    Z Kardiol; 1998 Sep; 87(9 Suppl):1-4. PubMed ID: 9795420
    [No Abstract]   [Full Text] [Related]  

  • 53. [Thrombolytic therapy in acute coronary syndrome--Part II].
    Barbash G
    Harefuah; 1989 Feb; 116(4):210-3. PubMed ID: 2659447
    [No Abstract]   [Full Text] [Related]  

  • 54. Enoxaparin for acute coronary syndromes?
    Pechlaner C; Gritsch W; Wiedermann C
    J Am Coll Cardiol; 2001 Jun; 37(7):2007-8. PubMed ID: 11401148
    [No Abstract]   [Full Text] [Related]  

  • 55. [Current principles of thrombolytic therapy of acute coronary syndrome without ST elevation].
    Dudka PF; Il'nyts'kyĭ PI; Lukasevych LM; Ktitareva VI; Mykhaĭlevs'ka TV
    Lik Sprava; 2004; (3-4):15-20. PubMed ID: 15318818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The pharmacological treatment of acute coronary syndromes].
    Moreno Gómez R; López-Sendón Hentschel JL; López de Sá Areses E; Rubio Sanz R; Pérez Castellano N; Delcán Domínguez JL
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):13-25. PubMed ID: 9139328
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacological thrombolysis in acute myocardial infarction. Lessons learned from ISIS-2 and GUSTO-1. I].
    Jerjes-Sánchez C; Garza-Ruiz A; Gutiérrez-Fajardo P
    Arch Inst Cardiol Mex; 1999; 69(5):478-87. PubMed ID: 10640212
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.
    Kamat SG; Schafer AI
    Coron Artery Dis; 1995 Dec; 6(12):930-5. PubMed ID: 8723014
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapy with thrombolytic agents in coronary artery disease.
    Hanna GP; Smalling RW
    Curr Opin Cardiol; 1998 Jul; 13(4):267-73. PubMed ID: 10091022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based risk stratification to target therapies in acute coronary syndromes.
    Cannon CP
    Circulation; 2002 Sep; 106(13):1588-91. PubMed ID: 12270844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.